Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

iBio, Inc. (IBIO)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.7087-0.0025 (-0.35%)
At close: 04:00PM EST
0.7100 +0.00 (+0.18%)
After hours: 04:37PM EST
Advertisement
Full screen
Loading interactive chart...
  • Insider Monkey

    10 Biotech Penny Stocks to Buy Now

    In this article, we discuss the 10 biotech penny stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to the 5 Biotech Penny Stocks to Buy Now. The fears around the spread of the coronavirus have returned to haunt people around the world as governments scramble to […]

  • GlobeNewswire

    ISS Joins Glass Lewis in Recommending Shareholders Vote “FOR” All Proposals Ahead of iBio’s Upcoming Annual Meeting

    - iBio’s Board Urges Shareholders to Vote Today to Support Company’s Strategic Growth Plans - BRYAN, Texas, Nov. 30, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, today announced that Institutional Shareholder Services, Inc. (“ISS”) has joined Glass Lewis and Co., LLC (“Glass Lewis”) in recommending that the Company’s stockholders vote “F

  • GlobeNewswire

    Omicron Variant Underscores Need for New COVID Vaccine Candidates Like IBIO-202

    - Global Reliance on Spike Protein-Based Vaccines May Create Public Health Risks - - Omicron’s Many Mutations Occur in Regions Outside Those of IBIO-202’s Nucleocapsid Antigen - - Company Expecting Feedback from U.S. FDA on IBIO-202 in January - BRYAN, Texas, Nov. 29, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming Manufacturing System®, today announced an update for its lead

Advertisement
Advertisement